Cargando…
Lung donation and SARS‐CoV‐2 transmission: Missed detection versus missed opportunity?
Point‐of‐care tests may play a valuable role in reducing the risk of donor‐derived SARS‐CoV‐2 transmission in lung transplantation.[Image: see text]
Autores principales: | Van Slambrouck, Jan, Van Raemdonck, Dirk, Wauters, Joost, Vos, Robin, Mombaerts, Peter, Ceulemans, Laurens J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8939038/ https://www.ncbi.nlm.nih.gov/pubmed/35349750 http://dx.doi.org/10.1002/iid3.603 |
Ejemplares similares
-
Persistence of SARS-CoV-2 RNA in lung tissue after mild COVID-19
por: Ceulemans, Laurens J, et al.
Publicado: (2021) -
Visualising SARS-CoV-2 infection of the lung in deceased COVID-19 patients
por: Van Slambrouck, Jan, et al.
Publicado: (2023) -
Donor lung preservation for transplantation—where do we go from here?
por: Van Raemdonck, Dirk, et al.
Publicado: (2022) -
SARS-CoV-2 RNA in Explant Lung Tissue from Patients with COVID-19 ARDS
por: Van Slambrouck, J., et al.
Publicado: (2022) -
Commentary: Donor lungs allocated to critically ill patients listed urgently: No longer a waste of precious organs?
por: Van Raemdonck, Dirk, et al.
Publicado: (2021)